INTRODUCTION
The pancreas is a non-encapsulated, retroperitoneal organ that is present in the anterior para-renal space among the duodenal loop and splenic hilum over a length of 12.5-15 cm. There are numerous types of morphological variations in the pancreas which have been labeled in patients with diabetes mellitus (DM). Islet cell pancreatic changes in diabetes mellitus such as hyalinization, fibrosis, hydropic degeneration, and hyperplasia are well shown. Additionally, cellular composition of the pancreas in Type 2 diabetes have shown a decrease in beta cell mass. 1 DM is a chronic metabolic disorder of various etiology, categorized by hyperglycemia with changes in carbohydrate, fat, and protein metabolism, resulting from a relative or an absolute lack of insulin. There are two types of diabetes; the Type 1 DM (IDDM) and the Type 2 DM (non-IDDM). In Type 1 DM, there is autoimmune attack and damage of the pancreas insulin-producing cells; whereas in Type 2 DM, the pancreas loses its capacity to appropriately produce and release insulin and the body also becomes resistant to insulin, thereby producing the blood sugar levels to rise. 2 The worldwide incidence of DM has risen intensely over the past two decades. 3 There are two types of DM: type I which is an autoimmune disorder with infiltration of inflammatory cells in Islets of Langerhans and distraction of pancreatic beta cells3 and type II which is characterized with disorder in insulin secretion, peripheral resistance to insulin and overproduction of glucose by liver. 4, 5 The ultrasound is a non-invasive imaging tool that sends the sound and receives the echoes to visualize in great detail organs. The placement of the pancreas in the abdomen suits best to view by ultrasound examination. Though, the complex anatomy of the organ and surrounding tissues make assessment a difficult task, and the ultrasound echo of the normal pancreas varies widely from patient to patient. 6 Hence this study evaluated the pancreatic size of diabetic patients using ultrasonography and also accessed whether there is an association among the size of the pancreas and the duration of diabetes.
MATERIAL AND METHODS
This observational study was conducted from the cases admitted to Malla Reddy Institute of Medical Sciences Hospital, Hyderabad during the period from June 2015 to October 2016. 30 cases of each type of diabetes were selected in this study. Ultrasound investigations were performed to measure pancreas head and diameter by using ultrasound
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machine Toshiba-Xario100 transabdominal convex transducer with frequency of 3.5 MHz. Inclusion criteriathe study included all patients above 20 years old, who they had diabetes milletus (type -1 and 2). Exclusion criteria -Patients of pediatric age group and had any pancreatic abnormalities (cirrhosis, thalassemia, pancreatitis, pancreatic tumors or cystic fibrosis). Cases selection was performed based on history, clinical examination and ultrasound examination. The echogenicity of pancreas was related to that of liver (as a reference). Study was conducted under the following parameters: History taking, Clinical examination and Ultrasound examination.
STATISTICAL ANALYSIS
Data collection and analysis were done by using Statistical Package for Social Sciences (SPSS) software (version 16, SPSS, Inc, Chicago, IL, USA) for both study groups. Oneway ANOVA test and Student's T-test were performed to estimate the size of head and body of pancreas and pancreas echogenicity in various groups. Pearson correlation was performed to assess the relationship between the size of the pancreas and the duration of diabetes.
RESULTS
There was a significant difference (P=0.001) observed when comparing mean pancreatic body size of diabetic patients group (type I and II) to that of control group. Mean pancreatic head and body size was 17.5 ± 2.5 mm and 7.4 ± 1.6 mm in insulin dependent diabetic patients and 21.1 ± 3.5 mm and 9.0 ± 2.1 mm in noninsulin dependent diabetic patients and 26.2 ± 4 mm and 14.1 ± 2.6 mm in the control group (table 1) . A statistically significance observed among the three groups (P<0.001). In all three groups, the control group observed the highest value, whereas the type I DM patients showed the smallest value of pancreas head and body size. No significant difference in pancreas echogenicity was noted among the groups. There was a negative correlation observed between the size of pancreas head and body with the duration of disease (P<0.001).
DISCUSSION
About 171 million people had diabetes mellitus globally by the year 2000, and the total number is established to rise to 366 million by 2030. The incidence of diabetes is 9.8%, with a male: female ratio of 1.4:1 and this upsurge in the incidence of diabetes mellitus in developing countries due to development of urbanization and lifestyle deviations, most prominently being the western style diet. 7 The quick-tempered increase in number of people identified with diabetes mellitus stances a overwhelming negative economic impact and human cost creating this disease a new health risk in the 21st century. Considering the etiology of the disease, ensuring quick diagnosis and outcome a way to prevent it is a crucial challenge for health care providers. 8 Diabetes mellitus affects both the lifespan and quality of life of the individual. The disease causes serious restraints on the patient's activities, especially when there is poor management of the disorder. This creates the diabetic person to be partially or totally dependent. 9, 10 Abdominal ultrasound has a great benefit over plain radiography in that it does not prompt tissues to the danger of ionizing radiation. Ultrasound is commonly far superior than plain radiography in uniqueness for understanding variation of soft tissue structure. Result of this study presented that the antero-posterior diameter of head and body of pancreas had significantly reduced in the diabetic group when compared with healthy controls. This was in concurrence of earlier studies. 11, 12 An earlier study on autopsy samples by Foulis et al established that in type I diabetic patients, irrespective of whether or not greater than 23 percent of island cells are affected by insulitis (inflammatory cell infiltration), significant reductions happen in the size and weight of pancreas 13 ; additional studies have documented lack of the trophic effect of insulin as the reason. 14 Our results noted that the mean diameters of head and body of pancreas in types I and II diabetes mellitus patients were significantly changed when compared with healthy controls. Type I diabetic patient had the smallest mean values whereas healthy controls had the largest values. Previous studies showed that diameters of pancreas were greatly reduced in type I diabetes mellitus compared with type II DM and these were significantly less than in the normal group. 13, 15 Conferring to the results of this study and other studies, it is concluded that ultrasonography could be a suitable technique for distinguishing two types of diabetes mellitus; for functional uses, though, more relative evaluation of the two groups is essential. Unlike type II diabetic patients, pancreatic head diameter in type I diabetic patients was less than 15 mm. From this study, there was a direct correlation between head and body of pancreas; also an inverse correlation was observed between these two diameters and period of disease. A study performed by Altobelli et al (1988) demonstrated that longer duration of disease is achieved by greater decrease in pancreatic size 16 , but the study of Foulis in 1984 didn't validate this result 12 ; echogenicity of the pancreas was considerably different. However Walls et al., 17 observed an increased echogenicity of the gland in type II diabetes compared with type I diabetes patients. 18 For further investigation, studies with greater sample size is necessary. In view of the fluctuating results of earlier studies, this work attempted to estimate ultrasonographic deviations of pancreas in diabetic patients. 
